“…It was shown earlier that modifications of Pro 2 in the sequence of EMs could yield proteolytically stable, yet MOP-active compounds, ,,− as such modifications do not alter the main pharmacophore groups. ,, Such modifications included the substitution of Pro 2 with 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (Tic), pseudoprolines (ΨPro), six-membered heterocyclic rings, such as piperidine-2-, 3-, and 4-carboxylic acids (( S )-Pip, ( R )-Nip, and Inp, respectively), four-membered azetidine rings (Aze, 3Aze), and alicyclic β-amino acids (Acpc, 2-aminocyclopentane-1-carboxylic acid; Achc, 2-aminocyclohexane-1-carboxylic acid) (Figure ) . Systematic review of these results suggests the importance of ring structure and size in determining the bioactivity of the ligands.…”